ACADIA Pharmaceuticals Inc. ACAD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 69.92% | 766.10% | -98.67% | 281.13% | 169.18% |
| Total Depreciation and Amortization | 15.71% | 5.48% | 2.36% | -0.88% | 0.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.55% | 88.42% | 105.96% | -2,064.85% | -5.67% |
| Change in Net Operating Assets | -296.52% | 198.95% | 115.02% | -602.20% | -158.09% |
| Cash from Operations | -88.59% | 196.58% | 169.73% | -165.60% | 16.15% |
| Capital Expenditure | 75.63% | 2.36% | -30.14% | -932.22% | -30.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,368.40% | -104.81% | 237.85% | 34.32% | -83.65% |
| Cash from Investing | -910.12% | -112.87% | 218.64% | 29.59% | -83.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.12% | 148.03% | -81.33% | 140.54% | -40.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.12% | 148.03% | -81.33% | 140.54% | -40.94% |
| Foreign Exchange rate Adjustments | 488.89% | 8.00% | 257.14% | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -160.93% | -1.67% | 227.57% | -1,979.49% | -88.10% |